BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18523991)

  • 1. Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia.
    Sonabend RY; McKay SV; Okcu MF; Yan J; Haymond MW; Margolin JF
    Pediatr Blood Cancer; 2008 Sep; 51(3):387-92. PubMed ID: 18523991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia.
    Sonabend RY; McKay SV; Okcu MF; Yan J; Haymond MW; Margolin JF
    J Pediatr; 2009 Jul; 155(1):73-8. PubMed ID: 19394046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
    Lausen B; Schmiegelow K; Andreassen B; Madsen HO; Garred P
    Eur J Haematol; 2006 Jun; 76(6):481-7. PubMed ID: 16494622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality.
    Ali NA; O'Brien JM; Blum W; Byrd JC; Klisovic RB; Marcucci G; Phillips G; Marsh CB; Lemeshow S; Grever MR
    Cancer; 2007 Jul; 110(1):96-102. PubMed ID: 17534900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia.
    Afzal S; Ethier MC; Dupuis LL; Tang L; Punnett AS; Richardson SE; Allen U; Abla O; Sung L
    Pediatr Infect Dis J; 2009 Dec; 28(12):1064-8. PubMed ID: 19773675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient hyperglycemia during childhood acute lymphocytic leukemia chemotherapy: an old event revisited.
    Spinola-Castro AM; Siviero-Miachon AA; Andreoni S; Tosta-Hernandez PD; Macedo CR; Lee ML
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):465-72. PubMed ID: 19701154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strict glycemic targets need not be so strict: a more permissive glycemic range for critically ill children.
    Ulate KP; Lima Falcao GC; Bielefeld MR; Morales JM; Rotta AT
    Pediatrics; 2008 Oct; 122(4):e898-904. PubMed ID: 18779254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia.
    Graubner UB; Porzig S; Jorch N; Kolb R; Wessalowski R; Escherich G; Janka GE
    Pediatr Blood Cancer; 2008 Feb; 50(2):259-63. PubMed ID: 17635005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia is associated with morbidity in critically ill children with meningococcal sepsis.
    Day KM; Haub N; Betts H; Inwald DP
    Pediatr Crit Care Med; 2008 Nov; 9(6):636-40. PubMed ID: 18838926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991.
    Yoshida M; Tsubaki K; Kobayashi T; Tanimoto M; Kuriyama K; Murakami H; Minami S; Hiraoka A; Takahashi I; Naoe T; Asou N; Kageyama S; Tomonaga M; Saito H; Ohno R
    Int J Hematol; 1999 Dec; 70(4):261-7. PubMed ID: 10643152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A protocolized approach to identify and manage hyperglycemia in a pediatric critical care unit.
    Preissig CM; Hansen I; Roerig PL; Rigby MR
    Pediatr Crit Care Med; 2008 Nov; 9(6):581-8. PubMed ID: 18838924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycemia in acute aluminum phosphide poisoning as a potential prognostic factor.
    Mehrpour O; Alfred S; Shadnia S; Keyler DE; Soltaninejad K; Chalaki N; Sedaghat M
    Hum Exp Toxicol; 2008 Jul; 27(7):591-5. PubMed ID: 18829736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucocutaneous findings in febrile neutropenic children with acute leukemias.
    Wananukul S; Nuchprayoon I; Siripanich H
    J Med Assoc Thai; 2005 Jun; 88(6):817-23. PubMed ID: 16083222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia.
    Roberson JR; Raju S; Shelso J; Pui CH; Howard SC
    Pediatr Blood Cancer; 2008 Jun; 50(6):1207-12. PubMed ID: 18266226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk childhood acute lymphoblastic leukemia in China: factors influencing the treatment and outcome.
    Luo XQ; Ke ZY; Huang LB; Guan XQ; Zhang YC; Zhang XL
    Pediatr Blood Cancer; 2009 Feb; 52(2):191-5. PubMed ID: 18989886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes.
    Bakhshi S; Padmanjali KS; Arya LS
    Pediatr Hematol Oncol; 2008 Jun; 25(5):385-92. PubMed ID: 18569840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrition and acute leukemia in adults: relation between nutritional status and infectious complications during remission induction.
    Eriksson KM; Cederholm T; Palmblad JE
    Cancer; 1998 Mar; 82(6):1071-7. PubMed ID: 9506351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases: a multicenter study from Turkey.
    Celkan T; Berrak S; Kazanci E; Ozyürek E; Unal S; Uçar C; Yilmaz S; Gürgey A
    Turk J Pediatr; 2009; 51(3):207-13. PubMed ID: 19817262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of hyperglycemia on risk of infection and early death during induction therapy for acute lymphoblastic leukemia (ALL).
    Dare JM; Moppett JP; Shield JP; Hunt LP; Stevens MC
    Pediatr Blood Cancer; 2013 Dec; 60(12):E157-9. PubMed ID: 23868820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.